author-photo

Jameel Muzaffar

University of Arkansas for Medical Sciences

54

Papers

129

Citations

Citation Trend

Filter By

Papers (36) Sort By

Journal Conference Others

Chordomas and chondrosarcomas of the skull base: treatment and outcome analysis in a consecutive case series of 24 patients.

2021 World Journal of Surgical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Survival results of phase I dose escalation of stereotactic body radiation therapy and concurrent cisplatin for re-irradiation of unresectable, recurrent head and neck squamous cell carcinoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Metagenomics and chemotherapy-induced nausea: A roadmap for future research

2021 Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Trial in progress: A phase I/II trial of novel MDM2 inhibitor alrizomadlin (APG-115), with or without platinum chemotherapy, in patients with p53 wild-type salivary gland carcinoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of concurrent cetuximab (CTX) and nivolumab (NIVO) in previously untreated recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
ARTISTRY-1: Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Acute Acoustic Trauma and Blast-Related Hearing Loss

2021
Show All
- Source
- Cite
- Save
Citations (0)
Correlation between thyroid fine needle aspiration cytology and post-operative histology: A 10-year single-centre experience

2021 Oral Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Correlation Between Thyroid Fine Needle Aspiration Cytology and Postoperative Histology: A 10-Year Single-Centre Experience

2021 Cureus
Show All
- Source
- Cite
- Save
Citations (0)
Randomized, phase II study of ficlatuzumab with or without cetuximab in patients with pan-refractory, recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)